Skip to Main Content
Phase II

A Phase 2a Study of LAM-001 for the Treatment of Pulmonary Hypertension

  • Study HIC#:2000035353
  • Last Updated:03/25/2024

This is a research study that aims to evaluate the effectiveness of sirolimus in individuals with pulmonary hypertension.

  • Age18 years and older
  • GenderBoth

Contact Us

For more information about this study, including how to volunteer, contact:

Anna Hessler

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.

Trial Purpose and Description

This is a research study that aims to evaluate the effectiveness of sirolimus in individuals with pulmonary hypertension.

Eligibility Criteria

Individuals aged 18+ diagnosed with pulmonary hypertension

Principal Investigator

Sub-Investigator

For more information about this study, including how to volunteer, contact: